COMP <GO>
AVTR vs TXG // FORWARD P/E MULTIPLE
Avantor Inc. (NYSE) VS. 10x Genomics Inc. (NASDAQ) • 15-METRIC TALLY: AVTR 5
— TXG 7
▲ FORWARD P/E MULTIPLE LEADER: TXG
LAST: $16.05 (-3.78%) • MKT CAP: $11.30B
forward-pe
31.0x
LAST: $70.11 (-14.03%) • MKT CAP: $10.63B
forward-pe
24.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVTR VS. TXG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVTR | TXG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.70% | 69.10% | -36.40 | TXG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.10% | -5.70% | +3.60 | AVTR | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.38% | 1.22% | +3.16 | AVTR | /fcf-yield <GO> |
| Operating Margin | -3.80% | -9.50% | +5.70 | AVTR | /operating-margins <GO> |
| Net Profit Margin | -8.10% | -6.80% | -1.30 | TXG | /net-margins <GO> |
| Revenue Growth (YoY) | -3.40% | 5.20% | -8.60 | TXG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 25.02 | -23.14 | TXG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TXG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.4 | 55.0 | +2.40 | AVTR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.15 | -0.14 | TXG | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 31.0x | 24.0x | +7.00 | TXG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.30B | $10.63B | $677.4M | AVTR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVTR REV | TXG REV | AVTR GROSS % | TXG GROSS % | AVTR FCF | TXG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.55B | $642.8M | 32.7% | 69.1% | $495.0M | $130.1M |
| FY 2024 | $6.78B | $610.8M | 33.6% | 67.9% | $692.0M | -$5.7M |
| FY 2023 | $6.97B | $618.7M | — | — | $556.5M | -$43.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVTR // BETA 1.01
TXG // BETA 1.15